These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Con: Antifibrinolytics are not safe and effective in patients undergoing liver transplantation. Ramsay MA J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):891-3. PubMed ID: 17138102 [No Abstract] [Full Text] [Related]
3. Pro: Antifibrinolytics are safe and effective in patients undergoing liver transplantation. Lerner AB J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):888-90. PubMed ID: 17138101 [No Abstract] [Full Text] [Related]
4. Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy. Cooper JR; Abrams J; Frazier OH; Radovancevic R; Radovancevic B; Bracey AW; Kindo MJ; Gregoric ID J Thorac Cardiovasc Surg; 2006 May; 131(5):963-8. PubMed ID: 16678576 [TBL] [Abstract][Full Text] [Related]
5. Antifibrinolytics in orthotopic liver transplantation: current status and controversies. Xia VW; Steadman RH Liver Transpl; 2005 Jan; 11(1):10-8. PubMed ID: 15690531 [TBL] [Abstract][Full Text] [Related]
6. Aprotinin and the risk of thrombotic complications after liver transplantation: a retrospective analysis of 1492 patients. Warnaar N; Mallett SV; Klinck JR; de Boer MT; Rolando N; Burroughs AK; Jamieson NV; Rolles K; Porte RJ Liver Transpl; 2009 Jul; 15(7):747-53. PubMed ID: 19562708 [TBL] [Abstract][Full Text] [Related]
7. Thrombosis after hypothermic circulatory arrest for cardiovascular surgery, antifibrinolytic drugs, and thrombophilia. Casati V; Zanetti PP; D'Angelo A Anesthesiology; 2007 Apr; 106(4):874; author reply 874-5. PubMed ID: 17413929 [No Abstract] [Full Text] [Related]
8. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Molenaar IQ; Warnaar N; Groen H; Tenvergert EM; Slooff MJ; Porte RJ Am J Transplant; 2007 Jan; 7(1):185-94. PubMed ID: 17227567 [TBL] [Abstract][Full Text] [Related]
9. A fatal thrombotic complication during liver transplantation after aprotinin administration. Baubillier E; Cherqui D; Dominique C; Khalil M; Bonnet F; Fagniez PL; Duvaldestin P Transplantation; 1994 Jun; 57(11):1664-6. PubMed ID: 7516589 [No Abstract] [Full Text] [Related]
10. Antifibrinolytics in liver transplantation. Groenland TH; Porte RJ Int Anesthesiol Clin; 2006; 44(3):83-97. PubMed ID: 16832208 [No Abstract] [Full Text] [Related]
11. Aprotinin administration and pulmonary thromboembolism during orthotopic liver transplantation: report of two cases. Fitzsimons MG; Peterfreund RA; Raines DE Anesth Analg; 2001 Jun; 92(6):1418-21. PubMed ID: 11375816 [No Abstract] [Full Text] [Related]
12. Cardiovascular collapse due to massive pulmonary thromboembolism during orthotopic liver transplantation. Ellenberger C; Mentha G; Giostra E; Licker M J Clin Anesth; 2006 Aug; 18(5):367-71. PubMed ID: 16905083 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary thromboembolism during liver transplantation: possible association with antifibrinolytic drugs and novel treatment options. O'Connor CJ; Roozeboom D; Brown R; Tuman KJ Anesth Analg; 2000 Aug; 91(2):296-9. PubMed ID: 10910835 [TBL] [Abstract][Full Text] [Related]
14. Four cases of cardiopulmonary thromboembolism during liver transplantation without the use of antifibrinolytic drugs. Lerner AB; Sundar E; Mahmood F; Sarge T; Hanto DW; Panzica PJ Anesth Analg; 2005 Dec; 101(6):1608-1612. PubMed ID: 16301227 [TBL] [Abstract][Full Text] [Related]
15. Epsilon-Aminocaproic Acid Has No Association With Thromboembolic Complications, Renal Failure, or Mortality After Liver Transplantation. Nicolau-Raducu R; Ku TC; Ganier DR; Evans BM; Koveleskie J; Daly WJ; Fish B; Cohen AJ; Reichman TW; Bohorquez HE; Bruce DS; Carmody IC; Loss GE; Gitman M; Marshall T; Nossaman BD J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):917-23. PubMed ID: 27020101 [TBL] [Abstract][Full Text] [Related]